Marks Peter Ashley purchased 47,620 ALTERITY THERAPEUTICS LTD shares at $0.50 per share on August 31, 2026. The transaction matters to investors because it records a director’s direct share ownership and leaves Ashley holding 191,340 shares after the purchase, while the transaction record also references derivative securities.

Key Highlights

  • The purchase price was $0.50 per ALTERITY THERAPEUTICS LTD share.
  • Marks Peter Ashley held 191,340 shares after the transaction.
  • The transaction record also lists 47,620 derivative securities at $0.50 per share.

Marks Peter Ashley, a director of ALTERITY THERAPEUTICS LTD (NASDAQ: ATHE), purchased 47,620 shares on August 31, 2026. The filing records the purchase at $0.50 per share.

Director Purchase Details

The transaction was classified under code P. Following the purchase, Ashley owned 191,340 ALTERITY THERAPEUTICS LTD shares. The record also lists 47,620 derivative securities acquired at $0.50 per share on the same date. Ashley’s resulting holding of derivative securities was none. The record lists the share and derivative-security transactions separately and states the post-transaction holdings for each category. Ashley is identified as a director of ALTERITY THERAPEUTICS LTD. The purchase date was August 31, 2026, and the listed price for both the shares and derivative securities was $0.50 per share.